Home > Boards > US OTC > Medical - Drugs > Tenax Therapeutics, Inc. (TENX)

Yes...Lolol ..Go TENX!MBD

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
makingbiigdough Member Profile
 
Followed By 123
Posts 4,598
Boards Moderated 2
Alias Born 10/20/01
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 4:34:25 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:54:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2019 4:31:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/19/2019 4:32:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:34:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:34:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:33:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/18/2019 4:33:39 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:33:58 PM
Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial Business Wire - 3/11/2019 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 11:37:54 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2019 5:36:33 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/5/2019 2:08:30 PM
Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference Business Wire - 2/4/2019 8:30:00 AM
Tenax Therapeutics to Present at Biotech Showcase Investor Conference Business Wire - 1/4/2019 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/14/2018 3:45:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2018 4:07:59 PM
Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering Business Wire - 12/11/2018 4:00:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/10/2018 6:01:46 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 12/7/2018 5:12:47 PM
Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering Business Wire - 12/7/2018 1:02:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/6/2018 8:33:10 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/3/2018 5:28:07 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 11/20/2018 5:06:34 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/20/2018 4:33:39 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist